What We're Reading: Page 242
Industry reads hand-picked by our editors
Feb 22, 2019
Feb 21, 2019
-
The Colorado Sun
A push to fix Colorado’s lowest-in-the-nation vaccine rates has an unexpected critic: Jared Polis
-
The Wall Street Journal
Johnson & Johnson Is Subpoenaed for Talc Safety Information
-
C&EN
Epitranscriptomics: The new RNA code and the race to drug it
-
Scientific American
How drug company ads downplay risks
Feb 20, 2019
Feb 19, 2019
-
Reuters
Philippines revokes Sanofi's product license for dengue vaccine
-
The New York Times
As McKinsey Sells Advice, Its Hedge Fund May Have a Stake in the Outcome
-
Reuters
As medical costs mount, Japan to weigh cost-effectiveness in setting drug prices
-
Axios
Blockbuster drugs are stacking up orphan approvals
Feb 15, 2019
Feb 14, 2019
-
Law360
Insys thought it 'owned' doctors, former CEO testifies
-
CNBC
Pfizer still holds the lead in the erectile dysfunction market even as Viagra sales falter
-
Bloomberg
Biotech hedge fund bailed on drugmaker before its depression treatment scored
-
The Washington Post
The Sacklers have donated millions to museums. But their connection to the opioid crisis is threatening that legacy.
Feb 13, 2019
-
The Boston Globe
Former CEO says Insys founder pushed for higher doses of opioid
-
Kaiser Health News
Americans Cross Border Into Mexico To Buy Insulin At A Fraction Of U.S. Cost
-
The New York Times
Trump Pledged to End H.I.V. But His Policies Veer the Other Way.
Previous
